| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 9271706 | Osteoarthritis and Cartilage | 2005 | 8 Pages | 
Abstract
												Compared to the untreated ACLX condition, administering bisphosphonate immediately after loss of the ACL conserved bone mineral at the MCL enthesis, suggesting the potential to therapeutically influence joint-complex laxity and OA progression.
											Keywords
												
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Immunology, Allergology and Rheumatology
												
											Authors
												M.R. Ph.D., J.M. Ph.D., D.M.L. B.Sc., B. Ph.D., D.A. M.D., R.C. M.D., R.F. Ph.D., 
											